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ABSTRACT 
Anti-convulsant drugs elicited hypersensitivity syndrome could be a rare side effect of 
the primary line anticonvulsive medication like carbamazepine and alternative aromatic 
agents. We here mention a rare case of gastrointestinal and skin findings associated 
with carbamazepine administration that is incredibly uncommon and desires to be 
reportable. 
We report a study done on a 22-year woman with carbamazepine associated 
hypersensitivity syndrome, who developed diarrhea, fever and skin lesions. On 
withdrawal of carbamazepine and administration of methylprednisolone in the patient, 
all initial skin related symptoms, GIT symptoms were relieved and white blood 
corpuscle count normalized. Anticonvulsive drug hypersensitivity syndromes can 
present with a wide spectrum of unspecific symptoms, which the prescribing clinician 
should be aware of. 
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INTRODUCTION
Carbamazepine (CBZ) is one among the 
routinely administered medication for the 
treatment of simple and complex epileptic 
seizures, neuralgia and alcohol withdrawal 
syndrome. The drug has anticonvulsive and 
anticholinergic properties by reducing excessive 
nerve signals within the brain and restoring the 
conventional balance of nerve activity. Side 
effects include diarrhea, inflammatory bowel 
disease, aplasticanemia and blood disease 
additionally different rare conditions like cardio 
toxicity.[1, 2] 
Hypersensitivity reactions are basic 
unfavorable medication responses (ADR’s) 
identified with hostile to anti epileptics[3]. 
Cutaneal unfavorable responses to medicine 
happen in up to eight percent of the world overall 
public and in 2-3% of hospitalized patients. 
Aromatic anticonvulsants (phenytoin, 
phenobarbitone and carbamazepine) are the pre-
eminent regularly involved drugs for cutaneal 
ADR’s. Cutaneal emissions happen in one third of 
individuals who accept carbamazepine and it 
includes diffuse erythroderma, exanthematous 
rash, urticaria, purpuric petechiae, or a 
connective tissue syndrome any of which may 
happen from day eight to day sixteen when 
medicine has initiated[4]. Different medical 
science adverse effects of carbamazepine 
embrace drug hypersensitivity, exfoliative skin 
disease, erythema, and harmful dermal lysis. 
Development of rash is likewise partner in early 
cautioning of bone marrow toxicity. Abnormal 
liver perform and bone marrow suppression with 
deaths owing to anemia have in addition been 
reportable with carbamazepine [5]. Extraordinary 
responses of anti convulsant drugs incorporate 
myositis, lupus erythematosis-like syndrome, 
pustules, psoriasis, lichenoid responses and 
Anticonvulsant hypersensitivity syndrome 
(ACHS) [4]. 
ACHS was initially portrayed in 1950 yet 
disarray still proliferates in regards to the 
syndrome. The triad of fever, rash and inside 
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organ association happening 1-8 weeks after 
introduction to anticonvulsant drugs heralds this 
rare (1 in 1,000 to 10,000 exposures) however a 
serious reaction[4]. Fever, in conjunction with 
discomfort and pharyngitis, is frequently the first 
sign. This is followed by a rash which may vary 
from easy eruption (mild form) to lethal 
epidermal necrolysis (severe form). Inward organ 
association generally includes the liver, albeit 
different organs, for example, the kidney, CNS or 
lungs may also be involved [4]. 
We report an interesting case of ACHS-
drug hypersensitivity reaction affected via 
carbamazepine given to female patient with 
epilepsy. The notable characteristics of the 
presentation, judgment and administration of this 
condition are talked about beneath. 
CASE STUDY 
 22 years, old female, was admitted into 
tertiary care centre unit with history of 
seizures. 
Presenting complaints: Mrs.GD had been 
complaining of black color rashes all over the 
body since 10 days. She complained that ten days 
after intake of anti epileptic medicines, she 
developed a reddish maculo-papulous rash with 
pruritus affecting her entire body simultaneously 
she developed fever and watery diarrhea. She 
also developed mild lesions in oral mucosa which 
spread to the face, upper extremities, trunk and 
ultimately all over the body.  
Previous medical history: Mrs. GD’s medical 
history included epilepsy. She was operated for 
brain tumor in year 2007. Brain tumor was 
diagnosed when she experienced seizure in 2007. 
She was experiencing tremors and jerks from past 
one month before hospital admission. The patient 
had two uncomplicated vaginal deliveries, no 
smoking history and alcohol consumption. Her 
family history was clear. 
Drug history: Mrs. GD was taking: tab. sodium 
valproate 200mg twice daily, tab. carbamazepine 
200mg twice daily from one month for jerks that 
she was experiencing from one month.  
Physical examination 
O/E: She was moderately built. She was conscious 
and coherent. Mrs. GD was found to be an 
epileptic individual with a pulse rate of 35 to 50 
beats per minute. Neurological workup included 
EEG, CT scan of the brain, MRT but no intracranial 
pathology could be demonstrated. Her EEG 
showed abnormality indicative of seizures. Blood 
and CSF chemistry were unremarkable and serum 
as well as CSF tested negative for bacterial, viral, 
fungal or parasitic pathogens. 
Other results were 
On General examination: Slight pedal edema 
was seen in-patient with Pallor positive. 
Vital signs 
 Blood pressure: 110/70mmHg 
 Respiratory rate: 14 breaths per minute 
 Pulse rate: 90 beats/minute 
 CNS examination: plantar ↓↓ 
Laboratory findings showed an increased 
white blood cell count with relative eosinophilia 
(8% of total leukocytes), increased neutrophils 
(78%), decreased RBC count (3.25m/cmm), 
decreased hemoglobin (9 gm/dl), decreased 
serum albumin (3.7%) and elevated 
transaminases (AST of 40 U/L, ALT of 39 U/L). C-
reactive protein (CRP) level was 2.2 mg/dL. 
Serum creatinine and serum potassium level was 
found to be normal.Pus cells, blood cells and urine 
albumin 4+ were seen on urine examination. 
Chest x-ray and abdomen ultrasound was 
unremarkable. Stool cultures were negative for 
enteric pathogens and no occult blood could be 
detected. 
DIAGNOSIS 
It was suspected that the patient suffered 
from epilepsy and abdominal pain was thought to 
represent an epigastria aura. Rashes on her body 
were confirmed as exfoliative eczema that was 
suspected as drug iatrogenic. Severity of the 
lesion was more additional toward drug 
hypersensitivity. The condition of the patient 
worsened after 2 days and was referred to 
dermatology department in a tertiary care 
hospital. On body covering examination, multiple 
hyper-pigmented lesions and a few target lesions 
were found everywhere on the body and her oral 
tissue layer was found to be with mild lesions (Fig 
1 and Fig 2). She was diagnosed as having 
maculopapular eruptions owing to 
carbamazepine. The amount of SGPT was 
borderline high suggesting of liver involvement. 
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Albumin, blood cells, pus cells were indicative of 
Kidney involvement. 
Treatment plan 
The decision was to stop offending 
medication immediately and administered 
following medications. 
 Methyl Prednisolone- 10mg TID PO, 
 Tab. Mizolastine-BT 
 Tab.Pheniramine-25mg BD 
 Tab. Ascorbic acid-500mg OD 
 Injection Ranitidine i.v. Two times a day 
 Tab. Phenobarbital-30mg (mrg) + 60mg 
(nyt) BD 
 Calamine + aloe vera gel + liquid 
paraffinlotion BT 
 Petro gel-for local application in the 
morning. 
The Pharmacist was contacted to discuss 
about hypersensitivity induced by anticonvulsant 
drugs. Later CBZ was replaced with 
phenobarbitone and sodium valproate.  
Following withdrawal of CBZ and 
provision of corticosteroids i.v. 
methylprednisolone at a dose of 10 mg every day 
for one week) and antihistamines, the patient 
condition quickly improved, loose bowels halted. 
After 4 days oftreatment, sores subsided without 
any sequelae and liver enzymes returned to 
normal. 
DISCUSSION 
ACHS can exhibit with a wide range of 
manifestations, for example, skin sores, fever, and 
lymphadenopathy in combination with pathologic 
laboratory findings like leucocytosis/leucopenia 
and elevated liver enzymes. It has been depicted 
after introduction to, aromatic drugs such as CBZ, 
phenytoin and Phenobarbital[6].  
Our patient presented with classic 
symptoms of ACHS which included black color 
rash all over the body, fever and diarrhea and 
elevated liver enzymes ten days after initiation of 
CBZ therapy. Symptoms of patient worsened and 
required hospitalization. She had no history of 
medication related reactions, gastrointestinal, 
dermatological or cardiovascular issue and no 
obvious intense disease making ACDHS a possible 
conclusion. In our study, patient had liver and 
kidney involvement suggested by elevated SGPT 
and proteinuria. 
Onset of ACHS might develop one week to 
a few months after CBZ administration [7], the 
term "drug rash with symptom and general 
symptoms" (DRESS) has been awhile ago utilized. 
The precise mechanism of ACHS remains to be 
determined however is thought to be connected 
with enzymatic insufficiency or variation in the 
metabolism of anticonvulsants, and ethnic 
inclination with certain human leukocyte antigen 
subtypes [6]. 
The aromatic anticonvulsants (phenytoin, 
phenobarbital, and carbamazepine) are 
metabolized to hydroxylated aromatic 
compounds for example, arene oxides. If 
detoxification of this dangerous metabolite is 
deficient; the poisonous metabolite may tie to cell 
macromolecules bringing on cell necrosis or an 
auxiliary immunological reaction. Cross-reactivity 
among the aromatic anticonvulsants may be as 
high as 75%. Moreover, there is a familial 
propensity to hypersensitivity to anticonvulsants. 
Inside organ association influencing liver, lungs, 
lymphatic framework and kidneys may prompt 
confusion of the side effects[4].  
CBZ is well known to cause neutropenia 
and pancytopenia. Up to 1–2 cases for every year 
for every 100.000 subjects may create 
agranulocytosis as the most noticeably awful 
inconvenience complication[8]. People with 
"moderate liver metabolism" may be at 
exaggerated risk to develop "drug elicited 
hypersensitivity syndrome” because of the 
processing of harmful metabolites in the liver 
considerably even after CBZ has been totally 
cleared; CBZ hypersensitivity syndrome has 
additionally been coupled to acute liver failure. 
Enterocolitis may be brought about by 
different antiepileptic drugs. Diagnosis of enteric 
indication of ACHS is focused around a nearby 
transient relationship between medication 
exposure and development of loose bowels and 
additionally improvement once withdrawal of the 
inflicting drug like in our case.[9,10] 
Advancement of a rash throughout 
medication warrants withdrawal of the drug and 
if no option exists, desensitization might be 
considered [11]. Our patient started response 
within 7-10 days of initiating carbamazepine 
medication and which subsided within 5 days of 
cessation of medicine. Other medicationsthat 
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generally can be included in ACHS are 
antihistamines (H1-receptor blockers), 
epinephrine, glucocorticords, anabolic steroids 
and airway management depending upon the 
seriousness of the condition [12].  
In our case, patient received steroids and 
antihistamines and she was improved with given 
antihistamine and steroid medicine. 
Methylprednisolone was used in this patient that 
resulted in associate improvement of initial 
symptoms and standardization of the previously 
elevated white blood cell count. 
The role of glucocorticoids in the 
medicine of ACHS has been dubiously talked 
about [13]. Glucocorticoids diminish the levels of 
IL-5, which that is one in all the key growth 
factors for eosinophilic granulocytes (particularly 
in Esinophilic conditions)[6].  
We likewise found comparable case 
reports of angioedema and maculopapular 
ejections connected with carbamazepine by Elias 
et al., [11]  a case of drug iatrogenic hypersensitivity 
syndrome because of carbamazepine by 
Morimoto et al.[14]. The vicinity of the HLA-
A*3101 allele was connected with 
carbamazepine-induced hypersensitivity 
responses among subjects of Northern European 
lineage. The vicinity of the allele redoubled the 
danger of hypersensitivity reactions from 5.0% to 
26.0%[15]. Because of absence of pharmacogenetic 
research facility setup, we couldn't genotype our 
patient for the HLA-A*3101.  
In our case, because of promptly 
consideration of the patient in the hospital, 
culpable drug was ceased and patient was kept 
from going into the extreme phase of the 
response with internal organ involvement. As 
maculopapular rash is a first indication of bone 
marrow depression seen with aromatic 
anticonvulsants, doctors ought to must be vigilant 
in regards to this sort of response happening. 
CONSENT 
Written consent was obtained from the 
patient for publication of this case report and 
related pictures. 
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PHOTOGRAPHS 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1: Exfoliative dermatitis on legs seen 
in the patient after administration of 
Carbamazepine                      
 
 
 
 
Fig 2: Rashes on hands of the patient after 
administration of Carbamazepine                      
 
 
